{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T09:33:29Z","timestamp":1791452009452,"version":"4.3.3"},"reference-count":54,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2018.1346","type":"journal-article","created":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T15:14:15Z","timestamp":1540566855000},"page":"e181346","source":"Crossref","is-referenced-by-count":23,"title":["Association of Reduced Nicotine Content Cigarettes With Smoking Behaviors and Biomarkers of Exposure Among Slow and Fast Nicotine Metabolizers"],"prefix":"10.1001","volume":"1","author":[{"given":"Melissa","family":"Mercincavage","sequence":"first","affiliation":[{"name":"Center for Interdisciplinary Research on Nicotine Addiction, Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Lochbuehler","sequence":"additional","affiliation":[{"name":"Center for Interdisciplinary Research on Nicotine Addiction, Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Paul","family":"Wileyto","sequence":"additional","affiliation":[{"name":"Center for Interdisciplinary Research on Nicotine Addiction, Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia"},{"name":"Department of Biostatistics & Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal L.","family":"Benowitz","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, San Francisco"},{"name":"Department of Bioengineering & Therapeutic Sciences, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel F.","family":"Tyndale","sequence":"additional","affiliation":[{"name":"Centre for Addiction and Mental Health, Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada"},{"name":"Division of Brain & Therapeutics, Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caryn","family":"Lerman","sequence":"additional","affiliation":[{"name":"Center for Interdisciplinary Research on Nicotine Addiction, Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia"},{"name":"Abramson Cancer Center, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew A.","family":"Strasser","sequence":"additional","affiliation":[{"name":"Center for Interdisciplinary Research on Nicotine Addiction, Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia"},{"name":"Abramson Cancer Center, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2018,8,24]]},"reference":[{"issue":"24","key":"zoi180088r2","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1001\/jama.2017.16396","article-title":"Will the FDA\u2019s new tobacco strategy be a game changer?","volume":"318","author":"Rubin","year":"2017","journal-title":"JAMA"},{"issue":"11","key":"zoi180088r4","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1158\/1055-9965.EPI-07-0393","article-title":"Nicotine and carcinogen exposure with smoking of progressively reduced nicotine content cigarette.","volume":"16","author":"Benowitz","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"zoi180088r5","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1158\/1055-9965.EPI-11-0644","article-title":"Smoking behavior and exposure to tobacco toxicants during 6 months of smoking progressively reduced nicotine content cigarettes.","volume":"21","author":"Benowitz","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"10","key":"zoi180088r6","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1111\/add.12978","article-title":"Effect of reducing the nicotine content of cigarettes on cigarette smoking behavior and tobacco smoke toxicant exposure: 2-year follow up.","volume":"110","author":"Benowitz","year":"2015","journal-title":"Addiction"},{"issue":"14","key":"zoi180088r7","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1056\/NEJMsa1502403","article-title":"Randomized trial of reduced-nicotine standards for cigarettes.","volume":"373","author":"Donny","year":"2015","journal-title":"N Engl J Med"},{"issue":"10","key":"zoi180088r8","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1158\/1055-9965.EPI-13-0957","article-title":"Reduced nicotine cigarettes: smoking behavior and biomarkers of exposure among smokers not intending to quit.","volume":"23","author":"Hammond","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"zoi180088r9","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1360-0443.2009.02780.x","article-title":"Reduced nicotine content cigarettes: effects on toxicant exposure, dependence and cessation.","volume":"105","author":"Hatsukami","year":"2010","journal-title":"Addiction"},{"issue":"6","key":"zoi180088r10","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/ntr\/nts247","article-title":"Dose-response effects of spectrum research cigarettes.","volume":"15","author":"Hatsukami","year":"2013","journal-title":"Nicotine Tob Res"},{"issue":"1","key":"zoi180088r11","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/add.13603","article-title":"Reduced nicotine content cigarettes and use of alternative nicotine products: exploratory trial.","volume":"112","author":"Hatsukami","year":"2017","journal-title":"Addiction"},{"issue":"7","key":"zoi180088r12","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1158\/1055-9965.EPI-15-1088","article-title":"A randomized controlled trial of progressively reduced nicotine content cigarettes on smoking behaviors, biomarkers of exposure, and subjective ratings.","volume":"25","author":"Mercincavage","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"zoi180088r13","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1158\/1055-9965.EPI-14-0739","article-title":"Compensatory smoking from gradual and immediate reduction in cigarette nicotine content.","volume":"24","author":"Hatsukami","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"zoi180088r14","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/add.13636","article-title":"Impact of smoking reduced nicotine content cigarettes on sensitivity to cigarette price: further results from a multi-site clinical trial.","volume":"112","author":"Smith","year":"2017","journal-title":"Addiction"},{"issue":"10","key":"zoi180088r15","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1111\/j.1360-0443.2012.03906.x","article-title":"The combined effect of very low nicotine content cigarettes, used as an adjunct to usual Quitline care (nicotine replacement therapy and behavioural support), on smoking cessation: a randomized controlled trial.","volume":"107","author":"Walker","year":"2012","journal-title":"Addiction"},{"issue":"2-3","key":"zoi180088r16","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.drugalcdep.2006.06.017","article-title":"New lower nicotine cigarettes can produce compensatory smoking and increased carbon monoxide exposure.","volume":"86","author":"Strasser","year":"2007","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"zoi180088r17","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1093\/ntr\/nts214","article-title":"Nicotine reduction: strategic research plan.","volume":"15","author":"Hatsukami","year":"2013","journal-title":"Nicotine Tob Res"},{"issue":"7","key":"zoi180088r18","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.addbeh.2014.03.021","article-title":"Sex differences in response to reduced nicotine content cigarettes.","volume":"39","author":"Vogel","year":"2014","journal-title":"Addict Behav"},{"key":"zoi180088r19","article-title":"Sex differences in subjective responses to moderate versus very low nicotine content cigarettes [published online September 8, 2017].","author":"Perkins","journal-title":"Nicotine Tob Res"},{"issue":"1","key":"zoi180088r20","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00213-017-4755-x","article-title":"Sex differences in tobacco withdrawal and responses to smoking reduced-nicotine cigarettes in young smokers.","volume":"235","author":"Faulkner","year":"2018","journal-title":"Psychopharmacology (Berl)"},{"key":"zoi180088r21","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.drugalcdep.2016.08.620","article-title":"Evaluation of a reduced nicotine product standard: moderating effects of and impact on cannabis use.","volume":"167","author":"Pacek","year":"2016","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"zoi180088r22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/ntr\/ntw199","article-title":"Effects of 6-week use of reduced-nicotine content cigarettes in smokers with and without elevated depressive symptoms.","volume":"19","author":"Tidey","year":"2017","journal-title":"Nicotine Tob Res"},{"issue":"9","key":"zoi180088r23","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1093\/ntr\/ntw089","article-title":"Smoking topography characteristics of very low nicotine content cigarettes, with and without nicotine replacement, in smokers with schizophrenia and controls.","volume":"18","author":"Tidey","year":"2016","journal-title":"Nicotine Tob Res"},{"issue":"2","key":"zoi180088r24","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/clpt.2008.54","article-title":"Genetic influences in the variation in renal clearance of nicotine and cotinine.","volume":"84","author":"Benowitz","year":"2008","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"zoi180088r25","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.clpt.2004.02.011","article-title":"Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity.","volume":"76","author":"Dempsey","year":"2004","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"zoi180088r26","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/FPC.0b013e32832a404f","article-title":"Genetic and environmental influences on the ratio of 3'hydroxycotinine to cotinine in plasma and urine.","volume":"19","author":"Swan","year":"2009","journal-title":"Pharmacogenet Genomics"},{"issue":"9","key":"zoi180088r27","doi-asserted-by":"crossref","first-page":"e1005498","DOI":"10.1371\/journal.pgen.1005498","article-title":"A genome-wide association study of a biomarker of nicotine metabolism.","volume":"11","author":"Loukola","year":"2015","journal-title":"PLoS Genet"},{"issue":"7","key":"zoi180088r28","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1158\/1055-9965.EPI-12-0236","article-title":"Reproducibility of the nicotine metabolite ratio in cigarette smokers.","volume":"21","author":"St Helen","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"zoi180088r29","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1001\/jama.280.2.152","article-title":"Nicotine metabolism and intake in black and white smokers.","volume":"280","author":"P\u00e9rez-Stable","year":"1998","journal-title":"JAMA"},{"key":"zoi180088r30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pbb.2016.05.002","article-title":"Racial differences in the relationship between rate of nicotine metabolism and nicotine intake from cigarette smoking.","volume":"148","author":"Ross","year":"2016","journal-title":"Pharmacol Biochem Behav"},{"issue":"5","key":"zoi180088r31","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.clpt.2006.01.008","article-title":"Female sex and oral contraceptive use accelerate nicotine metabolism.","volume":"79","author":"Benowitz","year":"2006","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"zoi180088r32","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1080\/1462220031000158717","article-title":"Nicotine metabolite ratio as a predictor of cigarette consumption.","volume":"5","author":"Benowitz","year":"2003","journal-title":"Nicotine Tob Res"},{"issue":"4","key":"zoi180088r33","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/sj.mp.4001794","article-title":"Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from and usage of nicotine replacement therapy.","volume":"11","author":"Malaiyandi","year":"2006","journal-title":"Mol Psychiatry"},{"issue":"2","key":"zoi180088r34","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1158\/1055-9965.EPI-10-0674","article-title":"Nicotine metabolite ratio predicts smoking topography and carcinogen biomarker level.","volume":"20","author":"Strasser","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"zoi180088r35","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1080\/14622200701239605","article-title":"An association of CYP2A6 genotype and smoking topography.","volume":"9","author":"Strasser","year":"2007","journal-title":"Nicotine Tob Res"},{"issue":"17","key":"zoi180088r36","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1093\/jnci\/djr237","article-title":"Relationship between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 variation and smoking behaviors and lung cancer risk.","volume":"103","author":"Wassenaar","year":"2011","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"zoi180088r37","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/clpt.2010.3","article-title":"Genetic variation in nicotine metabolism predicts the efficacy of extended-duration transdermal nicotine therapy.","volume":"87","author":"Lerman","year":"2010","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"zoi180088r38","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.clpt.2006.02.006","article-title":"Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation.","volume":"79","author":"Lerman","year":"2006","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"zoi180088r39","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S2213-2600(14)70294-2","article-title":"Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial.","volume":"3","author":"Lerman","year":"2015","journal-title":"Lancet Respir Med"},{"issue":"8","key":"zoi180088r40","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1038\/npp.2017.18","article-title":"Reduced-nicotine cigarettes in young smokers: impact of nicotine metabolism on nicotine dose effects.","volume":"42","author":"Faulkner","year":"2017","journal-title":"Neuropsychopharmacology"},{"issue":"9","key":"zoi180088r41","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1093\/ntr\/ntu337","article-title":"Nicotine dependence, nicotine metabolism, and the extent of compensation in response to reduced nicotine content cigarettes.","volume":"17","author":"Bandiera","year":"2015","journal-title":"Nicotine Tob Res"},{"issue":"3","key":"zoi180088r42","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1158\/1055-9965.EPI-12-1097","article-title":"The effect of menthol on cigarette smoking behaviors, biomarkers and subjective responses.","volume":"22","author":"Strasser","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"zoi180088r43","doi-asserted-by":"crossref","first-page":"248","DOI":"10.18001\/TRS.3.3.1","article-title":"The importance of filter collection for accurate measurement of cigarette smoking.","volume":"3","author":"Saddleson","year":"2017","journal-title":"Tob Regul Sci"},{"issue":"8","key":"zoi180088r44","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1158\/1055-9965.EPI-14-1381","article-title":"Nicotine metabolite ratio (3-hydroxycotinine\/cotinine) in plasma and urine by different analytical methods and laboratories: implications for clinical implementation.","volume":"24","author":"Tanner","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"zoi180088r45","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/clpt.2008.57","article-title":"Toward personalized therapy for smoking cessation: a randomized placebo-controlled trial of bupropion.","volume":"84","author":"Patterson","year":"2008","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"zoi180088r46","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.pbb.2008.10.016","article-title":"Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: a validation study.","volume":"92","author":"Schnoll","year":"2009","journal-title":"Pharmacol Biochem Behav"},{"issue":"9","key":"zoi180088r47","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1360-0443.1991.tb01879.x","article-title":"The Fagerstr\u00f6m Test for Nicotine Dependence: a revision of the Fagerstr\u00f6m Tolerance Questionnaire.","volume":"86","author":"Heatherton","year":"1991","journal-title":"Br J Addict"},{"issue":"21","key":"zoi180088r48","doi-asserted-by":"crossref","first-page":"8115","DOI":"10.1021\/ac8009005","article-title":"Subpicogram per milliliter determination of the tobacco-specific carcinogen metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in human urine using liquid chromatography-tandem mass spectrometry.","volume":"80","author":"Jacob","year":"2008","journal-title":"Anal Chem"},{"issue":"3-4","key":"zoi180088r49","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jchromb.2010.12.012","article-title":"Determination of the nicotine metabolites cotinine and trans-3'-hydroxycotinine in biologic fluids of smokers and non-smokers using liquid chromatography-tandem mass spectrometry: biomarkers for tobacco smoke exposure and for phenotyping cytochrome P450 2A6 activity.","volume":"879","author":"Jacob","year":"2011","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"2","key":"zoi180088r50","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.pbb.2005.09.001","article-title":"The effect of filter vent blocking and smoking topography on carbon monoxide levels in smokers.","volume":"82","author":"Strasser","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"issue":"2","key":"zoi180088r51","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s00213-005-2167-9","article-title":"Reduced nicotine reward in obesity: cross-comparison in human and mouse.","volume":"180","author":"Blendy","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"issue":"9","key":"zoi180088r52","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1158\/1055-9965.EPI-14-0427","article-title":"Known and novel sources of variability in the nicotine metabolite ratio in a large sample of treatment-seeking smokers.","volume":"23","author":"Chenoweth","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"r","key":"zoi180088r53","article-title":"Reducing nicotine exposure results in weight gain in smokers randomised to very low nicotine content cigarettes.","author":"Rupprecht","journal-title":"Tob Control"},{"issue":"12","key":"zoi180088r54","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1111\/add.13519","article-title":"Estimations and predictors of non-compliance in switchers to reduced nicotine content cigarettes.","volume":"111","author":"Nardone","year":"2016","journal-title":"Addiction"},{"key":"zoi180088r1","unstructured":"FDA News Release. FDA announces comprehensive regulatory plan to shift trajectory of tobacco-related disease, death. https:\/\/www.fda.gov\/newsevents\/newsroom\/pressannouncements\/ucm568923.htm. Published July 28, 2017. Accessed October 5, 2017."},{"key":"zoi180088r3","unstructured":"Congress.gov. H.R.1256\u2014Family Smoking Prevention and Tobacco Control Act. 2009. https:\/\/www.congress.gov\/bill\/111th-congress\/house-bill\/1256. Accessed July 16, 2018."}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamanetworkopen\/article-pdf\/1\/4\/e181346\/17309175\/mercincavage_2018_oi_180088.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,20]],"date-time":"2019-02-20T21:35:09Z","timestamp":1550698509000},"score":1,"resource":{"primary":{"URL":"http:\/\/jamanetworkopen.jamanetwork.com\/article.aspx?doi=10.1001\/jamanetworkopen.2018.1346"}},"subtitle":["A Nonrandomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2018,8,24]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.1346","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,24]]}}}